ViiV Healthcare

Company snapshot

We are ViiV Healthcare: the only global pharmaceutical company 100% dedicated to preventing, treating and curing HIV. Unafraid to be first, we push the boundaries of what people think is possible – bringing together our transformational science and a deep understanding of the communities we serve – all to reach a HIV-free generation and ultimately, make HIV history. For job opportunities, please v

• 3 active pipeline program(s) linked via ClinicalTrials.gov.
• 3 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for ViiV Healthcare. Not investment advice.

• What is ViiV Healthcare?

  ViiV Healthcare is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include HIV Infections, Infection, Human Immunodeficiency Virus. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public

• Is ViiV Healthcare publicly traded?

  ViiV Healthcare appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does ViiV Healthcare develop or market?

  We link 5 drug profile(s) where ViiV Healthcare is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/viiv-healthcare-b-v#company-drugs.

• What are the latest developments for ViiV Healthcare?

  In the last 12 months our linked public records show 3 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does ViiV Healthcare focus on?

  ViiV Healthcare focuses on HIV Infections, Infection, Human Immunodeficiency Virus based on our analysis of their pipeline programs and drug development activities.